カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の腎臓がん診断市場2022年：免疫組織化学、尿分析、血液化学検査、その他

◆英語タイトル：Global Kidney Cancer Diagnostics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8015 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：107 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

腎臓がん診断市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の腎臓がん診断の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

腎臓がん診断市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・免疫組織化学、尿分析、血液化学検査、その他

用途別セグメントは次のように区分されます。
・病院、専門クリニック、その他

世界の腎臓がん診断市場の主要な市場プレーヤーは以下のとおりです。
・Thermo Fisher Scientific、Abbott Laboratories、Illumina、Quest Diagnostics Incorporated、Roche Holding、Myriad Genetics、NeoGenomics Laboratories、NanoString Technologies、Sysmex Corporation、Rosetta Genomics

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、腎臓がん診断製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な腎臓がん診断メーカーの企業概要、2019年～2022年までの腎臓がん診断の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な腎臓がん診断メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別腎臓がん診断の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの腎臓がん診断の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での腎臓がん診断市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および腎臓がん診断の産業チェーンを掲載しています。
・第13、14、15章では、腎臓がん診断の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Thermo Fisher Scientific、Abbott Laboratories、Illumina、Quest Diagnostics Incorporated、Roche Holding、Myriad Genetics、NeoGenomics Laboratories、NanoString Technologies、Sysmex Corporation、Rosetta Genomics
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：免疫組織化学、尿分析、血液化学検査、その他
・用途別分析2017年-2028年：病院、専門クリニック、その他
・腎臓がん診断の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・腎臓がん診断のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・腎臓がん診断のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・腎臓がん診断の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・腎臓がん診断の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Kidney Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Kidney Cancer Diagnostics market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Kidney Cancer Diagnostics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Immunohistochemistry segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Kidney Cancer Diagnostics include Thermo Fisher Scientific, Abbott Laboratories, Illumina, Quest Diagnostics Incorporated, and Roche Holding, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Kidney Cancer Diagnostics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immunohistochemistry
Urine Analysis
Blood Chemistry Test
Others
Market segment by Application can be divided into
Hospitals
Specialty Clinics
Others
The key market players for global Kidney Cancer Diagnostics market are listed below:
Thermo Fisher Scientific
Abbott Laboratories
Illumina
Quest Diagnostics Incorporated
Roche Holding
Myriad Genetics
NeoGenomics Laboratories
NanoString Technologies
Sysmex Corporation
Rosetta Genomics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Kidney Cancer Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Kidney Cancer Diagnostics, with price, sales, revenue and global market share of Kidney Cancer Diagnostics from 2019 to 2022.
Chapter 3, the Kidney Cancer Diagnostics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Kidney Cancer Diagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Kidney Cancer Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Kidney Cancer Diagnostics.
Chapter 13, 14, and 15, to describe Kidney Cancer Diagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Kidney Cancer Diagnostics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Kidney Cancer Diagnostics Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Immunohistochemistry
1.2.3 Urine Analysis
1.2.4 Blood Chemistry Test
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Kidney Cancer Diagnostics Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Global Kidney Cancer Diagnostics Market Size & Forecast
1.4.1 Global Kidney Cancer Diagnostics Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Kidney Cancer Diagnostics Sales in Volume (2017-2028)
1.4.3 Global Kidney Cancer Diagnostics Price (2017-2028)
1.5 Global Kidney Cancer Diagnostics Production Capacity Analysis
1.5.1 Global Kidney Cancer Diagnostics Total Production Capacity (2017-2028)
1.5.2 Global Kidney Cancer Diagnostics Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Kidney Cancer Diagnostics Market Drivers
1.6.2 Kidney Cancer Diagnostics Market Restraints
1.6.3 Kidney Cancer Diagnostics Trends Analysis
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Kidney Cancer Diagnostics Product and Services
2.1.4 Thermo Fisher Scientific Kidney Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Kidney Cancer Diagnostics Product and Services
2.2.4 Abbott Laboratories Kidney Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Kidney Cancer Diagnostics Product and Services
2.3.4 Illumina Kidney Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Quest Diagnostics Incorporated
2.4.1 Quest Diagnostics Incorporated Details
2.4.2 Quest Diagnostics Incorporated Major Business
2.4.3 Quest Diagnostics Incorporated Kidney Cancer Diagnostics Product and Services
2.4.4 Quest Diagnostics Incorporated Kidney Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Roche Holding
2.5.1 Roche Holding Details
2.5.2 Roche Holding Major Business
2.5.3 Roche Holding Kidney Cancer Diagnostics Product and Services
2.5.4 Roche Holding Kidney Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Myriad Genetics
2.6.1 Myriad Genetics Details
2.6.2 Myriad Genetics Major Business
2.6.3 Myriad Genetics Kidney Cancer Diagnostics Product and Services
2.6.4 Myriad Genetics Kidney Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 NeoGenomics Laboratories
2.7.1 NeoGenomics Laboratories Details
2.7.2 NeoGenomics Laboratories Major Business
2.7.3 NeoGenomics Laboratories Kidney Cancer Diagnostics Product and Services
2.7.4 NeoGenomics Laboratories Kidney Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 NanoString Technologies
2.8.1 NanoString Technologies Details
2.8.2 NanoString Technologies Major Business
2.8.3 NanoString Technologies Kidney Cancer Diagnostics Product and Services
2.8.4 NanoString Technologies Kidney Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Sysmex Corporation
2.9.1 Sysmex Corporation Details
2.9.2 Sysmex Corporation Major Business
2.9.3 Sysmex Corporation Kidney Cancer Diagnostics Product and Services
2.9.4 Sysmex Corporation Kidney Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Rosetta Genomics
2.10.1 Rosetta Genomics Details
2.10.2 Rosetta Genomics Major Business
2.10.3 Rosetta Genomics Kidney Cancer Diagnostics Product and Services
2.10.4 Rosetta Genomics Kidney Cancer Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Kidney Cancer Diagnostics Breakdown Data by Manufacturer
3.1 Global Kidney Cancer Diagnostics Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Kidney Cancer Diagnostics Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Kidney Cancer Diagnostics
3.4 Market Concentration Rate
3.4.1 Top 3 Kidney Cancer Diagnostics Manufacturer Market Share in 2021
3.4.2 Top 6 Kidney Cancer Diagnostics Manufacturer Market Share in 2021
3.5 Global Kidney Cancer Diagnostics Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Kidney Cancer Diagnostics Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Kidney Cancer Diagnostics Market Size by Region
4.1.1 Global Kidney Cancer Diagnostics Sales in Volume by Region (2017-2028)
4.1.2 Global Kidney Cancer Diagnostics Revenue by Region (2017-2028)
4.2 North America Kidney Cancer Diagnostics Revenue (2017-2028)
4.3 Europe Kidney Cancer Diagnostics Revenue (2017-2028)
4.4 Asia-Pacific Kidney Cancer Diagnostics Revenue (2017-2028)
4.5 South America Kidney Cancer Diagnostics Revenue (2017-2028)
4.6 Middle East and Africa Kidney Cancer Diagnostics Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Kidney Cancer Diagnostics Sales in Volume by Type (2017-2028)
5.2 Global Kidney Cancer Diagnostics Revenue by Type (2017-2028)
5.3 Global Kidney Cancer Diagnostics Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Kidney Cancer Diagnostics Sales in Volume by Application (2017-2028)
6.2 Global Kidney Cancer Diagnostics Revenue by Application (2017-2028)
6.3 Global Kidney Cancer Diagnostics Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Kidney Cancer Diagnostics Sales by Type (2017-2028)
7.2 North America Kidney Cancer Diagnostics Sales by Application (2017-2028)
7.3 North America Kidney Cancer Diagnostics Market Size by Country
7.3.1 North America Kidney Cancer Diagnostics Sales in Volume by Country (2017-2028)
7.3.2 North America Kidney Cancer Diagnostics Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Kidney Cancer Diagnostics Sales by Type (2017-2028)
8.2 Europe Kidney Cancer Diagnostics Sales by Application (2017-2028)
8.3 Europe Kidney Cancer Diagnostics Market Size by Country
8.3.1 Europe Kidney Cancer Diagnostics Sales in Volume by Country (2017-2028)
8.3.2 Europe Kidney Cancer Diagnostics Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Kidney Cancer Diagnostics Sales by Type (2017-2028)
9.2 Asia-Pacific Kidney Cancer Diagnostics Sales by Application (2017-2028)
9.3 Asia-Pacific Kidney Cancer Diagnostics Market Size by Region
9.3.1 Asia-Pacific Kidney Cancer Diagnostics Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Kidney Cancer Diagnostics Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Kidney Cancer Diagnostics Sales by Type (2017-2028)
10.2 South America Kidney Cancer Diagnostics Sales by Application (2017-2028)
10.3 South America Kidney Cancer Diagnostics Market Size by Country
10.3.1 South America Kidney Cancer Diagnostics Sales in Volume by Country (2017-2028)
10.3.2 South America Kidney Cancer Diagnostics Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Kidney Cancer Diagnostics Sales by Type (2017-2028)
11.2 Middle East & Africa Kidney Cancer Diagnostics Sales by Application (2017-2028)
11.3 Middle East & Africa Kidney Cancer Diagnostics Market Size by Country
11.3.1 Middle East & Africa Kidney Cancer Diagnostics Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Kidney Cancer Diagnostics Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Kidney Cancer Diagnostics and Key Manufacturers
12.2 Manufacturing Costs Percentage of Kidney Cancer Diagnostics
12.3 Kidney Cancer Diagnostics Production Process
12.4 Kidney Cancer Diagnostics Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Kidney Cancer Diagnostics Typical Distributors
13.3 Kidney Cancer Diagnostics Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Kidney Cancer Diagnostics Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Kidney Cancer Diagnostics Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 4. Thermo Fisher Scientific Major Business
Table 5. Thermo Fisher Scientific Kidney Cancer Diagnostics Product and Services
Table 6. Thermo Fisher Scientific Kidney Cancer Diagnostics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Laboratories Major Business
Table 9. Abbott Laboratories Kidney Cancer Diagnostics Product and Services
Table 10. Abbott Laboratories Kidney Cancer Diagnostics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Illumina Basic Information, Manufacturing Base and Competitors
Table 12. Illumina Major Business
Table 13. Illumina Kidney Cancer Diagnostics Product and Services
Table 14. Illumina Kidney Cancer Diagnostics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Quest Diagnostics Incorporated Basic Information, Manufacturing Base and Competitors
Table 16. Quest Diagnostics Incorporated Major Business
Table 17. Quest Diagnostics Incorporated Kidney Cancer Diagnostics Product and Services
Table 18. Quest Diagnostics Incorporated Kidney Cancer Diagnostics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Roche Holding Basic Information, Manufacturing Base and Competitors
Table 20. Roche Holding Major Business
Table 21. Roche Holding Kidney Cancer Diagnostics Product and Services
Table 22. Roche Holding Kidney Cancer Diagnostics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Myriad Genetics Basic Information, Manufacturing Base and Competitors
Table 24. Myriad Genetics Major Business
Table 25. Myriad Genetics Kidney Cancer Diagnostics Product and Services
Table 26. Myriad Genetics Kidney Cancer Diagnostics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. NeoGenomics Laboratories Basic Information, Manufacturing Base and Competitors
Table 28. NeoGenomics Laboratories Major Business
Table 29. NeoGenomics Laboratories Kidney Cancer Diagnostics Product and Services
Table 30. NeoGenomics Laboratories Kidney Cancer Diagnostics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. NanoString Technologies Basic Information, Manufacturing Base and Competitors
Table 32. NanoString Technologies Major Business
Table 33. NanoString Technologies Kidney Cancer Diagnostics Product and Services
Table 34. NanoString Technologies Kidney Cancer Diagnostics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Sysmex Corporation Basic Information, Manufacturing Base and Competitors
Table 36. Sysmex Corporation Major Business
Table 37. Sysmex Corporation Kidney Cancer Diagnostics Product and Services
Table 38. Sysmex Corporation Kidney Cancer Diagnostics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Rosetta Genomics Basic Information, Manufacturing Base and Competitors
Table 40. Rosetta Genomics Major Business
Table 41. Rosetta Genomics Kidney Cancer Diagnostics Product and Services
Table 42. Rosetta Genomics Kidney Cancer Diagnostics Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Kidney Cancer Diagnostics Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Kidney Cancer Diagnostics Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Kidney Cancer Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Kidney Cancer Diagnostics Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Kidney Cancer Diagnostics Production Site of Key Manufacturer
Table 48. Kidney Cancer Diagnostics New Entrant and Capacity Expansion Plans
Table 49. Kidney Cancer Diagnostics Mergers & Acquisitions in the Past Five Years
Table 50. Global Kidney Cancer Diagnostics Sales by Region (2017-2022) & (K Units)
Table 51. Global Kidney Cancer Diagnostics Sales by Region (2023-2028) & (K Units)
Table 52. Global Kidney Cancer Diagnostics Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Kidney Cancer Diagnostics Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Kidney Cancer Diagnostics Sales by Type (2017-2022) & (K Units)
Table 55. Global Kidney Cancer Diagnostics Sales by Type (2023-2028) & (K Units)
Table 56. Global Kidney Cancer Diagnostics Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Kidney Cancer Diagnostics Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Kidney Cancer Diagnostics Price by Type (2017-2022) & (US$/Unit)
Table 59. Global Kidney Cancer Diagnostics Price by Type (2023-2028) & (US$/Unit)
Table 60. Global Kidney Cancer Diagnostics Sales by Application (2017-2022) & (K Units)
Table 61. Global Kidney Cancer Diagnostics Sales by Application (2023-2028) & (K Units)
Table 62. Global Kidney Cancer Diagnostics Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Kidney Cancer Diagnostics Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Kidney Cancer Diagnostics Price by Application (2017-2022) & (US$/Unit)
Table 65. Global Kidney Cancer Diagnostics Price by Application (2023-2028) & (US$/Unit)
Table 66. North America Kidney Cancer Diagnostics Sales by Country (2017-2022) & (K Units)
Table 67. North America Kidney Cancer Diagnostics Sales by Country (2023-2028) & (K Units)
Table 68. North America Kidney Cancer Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Kidney Cancer Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Kidney Cancer Diagnostics Sales by Type (2017-2022) & (K Units)
Table 71. North America Kidney Cancer Diagnostics Sales by Type (2023-2028) & (K Units)
Table 72. North America Kidney Cancer Diagnostics Sales by Application (2017-2022) & (K Units)
Table 73. North America Kidney Cancer Diagnostics Sales by Application (2023-2028) & (K Units)
Table 74. Europe Kidney Cancer Diagnostics Sales by Country (2017-2022) & (K Units)
Table 75. Europe Kidney Cancer Diagnostics Sales by Country (2023-2028) & (K Units)
Table 76. Europe Kidney Cancer Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Kidney Cancer Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Kidney Cancer Diagnostics Sales by Type (2017-2022) & (K Units)
Table 79. Europe Kidney Cancer Diagnostics Sales by Type (2023-2028) & (K Units)
Table 80. Europe Kidney Cancer Diagnostics Sales by Application (2017-2022) & (K Units)
Table 81. Europe Kidney Cancer Diagnostics Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Kidney Cancer Diagnostics Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Kidney Cancer Diagnostics Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Kidney Cancer Diagnostics Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Kidney Cancer Diagnostics Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Kidney Cancer Diagnostics Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Kidney Cancer Diagnostics Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Kidney Cancer Diagnostics Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Kidney Cancer Diagnostics Sales by Application (2023-2028) & (K Units)
Table 90. South America Kidney Cancer Diagnostics Sales by Country (2017-2022) & (K Units)
Table 91. South America Kidney Cancer Diagnostics Sales by Country (2023-2028) & (K Units)
Table 92. South America Kidney Cancer Diagnostics Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Kidney Cancer Diagnostics Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Kidney Cancer Diagnostics Sales by Type (2017-2022) & (K Units)
Table 95. South America Kidney Cancer Diagnostics Sales by Type (2023-2028) & (K Units)
Table 96. South America Kidney Cancer Diagnostics Sales by Application (2017-2022) & (K Units)
Table 97. South America Kidney Cancer Diagnostics Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Kidney Cancer Diagnostics Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Kidney Cancer Diagnostics Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Kidney Cancer Diagnostics Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Kidney Cancer Diagnostics Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Kidney Cancer Diagnostics Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Kidney Cancer Diagnostics Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Kidney Cancer Diagnostics Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Kidney Cancer Diagnostics Sales by Application (2023-2028) & (K Units)
Table 106. Kidney Cancer Diagnostics Raw Material
Table 107. Key Manufacturers of Kidney Cancer Diagnostics Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Kidney Cancer Diagnostics Typical Distributors
Table 111. Kidney Cancer Diagnostics Typical Customers
List of Figures
Figure 1. Kidney Cancer Diagnostics Picture
Figure 2. Global Kidney Cancer Diagnostics Revenue Market Share by Type in 2021
Figure 3. Immunohistochemistry
Figure 4. Urine Analysis
Figure 5. Blood Chemistry Test
Figure 6. Others
Figure 7. Global Kidney Cancer Diagnostics Revenue Market Share by Application in 2021
Figure 8. Hospitals
Figure 9. Specialty Clinics
Figure 10. Others
Figure 11. Global Kidney Cancer Diagnostics Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Kidney Cancer Diagnostics Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Kidney Cancer Diagnostics Sales (2017-2028) & (K Units)
Figure 14. Global Kidney Cancer Diagnostics Price (2017-2028) & (US$/Unit)
Figure 15. Global Kidney Cancer Diagnostics Production Capacity (2017-2028) & (K Units)
Figure 16. Global Kidney Cancer Diagnostics Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Kidney Cancer Diagnostics Market Drivers
Figure 18. Kidney Cancer Diagnostics Market Restraints
Figure 19. Kidney Cancer Diagnostics Market Trends
Figure 20. Global Kidney Cancer Diagnostics Sales Market Share by Manufacturer in 2021
Figure 21. Global Kidney Cancer Diagnostics Revenue Market Share by Manufacturer in 2021
Figure 22. Kidney Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Kidney Cancer Diagnostics Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Kidney Cancer Diagnostics Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Kidney Cancer Diagnostics Sales Market Share by Region (2017-2028)
Figure 26. Global Kidney Cancer Diagnostics Revenue Market Share by Region (2017-2028)
Figure 27. North America Kidney Cancer Diagnostics Revenue (2017-2028) & (USD Million)
Figure 28. Europe Kidney Cancer Diagnostics Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Kidney Cancer Diagnostics Revenue (2017-2028) & (USD Million)
Figure 30. South America Kidney Cancer Diagnostics Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Kidney Cancer Diagnostics Revenue (2017-2028) & (USD Million)
Figure 32. Global Kidney Cancer Diagnostics Sales Market Share by Type (2017-2028)
Figure 33. Global Kidney Cancer Diagnostics Revenue Market Share by Type (2017-2028)
Figure 34. Global Kidney Cancer Diagnostics Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Kidney Cancer Diagnostics Sales Market Share by Application (2017-2028)
Figure 36. Global Kidney Cancer Diagnostics Revenue Market Share by Application (2017-2028)
Figure 37. Global Kidney Cancer Diagnostics Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Kidney Cancer Diagnostics Sales Market Share by Type (2017-2028)
Figure 39. North America Kidney Cancer Diagnostics Sales Market Share by Application (2017-2028)
Figure 40. North America Kidney Cancer Diagnostics Sales Market Share by Country (2017-2028)
Figure 41. North America Kidney Cancer Diagnostics Revenue Market Share by Country (2017-2028)
Figure 42. United States Kidney Cancer Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Kidney Cancer Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Kidney Cancer Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Kidney Cancer Diagnostics Sales Market Share by Type (2017-2028)
Figure 46. Europe Kidney Cancer Diagnostics Sales Market Share by Application (2017-2028)
Figure 47. Europe Kidney Cancer Diagnostics Sales Market Share by Country (2017-2028)
Figure 48. Europe Kidney Cancer Diagnostics Revenue Market Share by Country (2017-2028)
Figure 49. Germany Kidney Cancer Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Kidney Cancer Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Kidney Cancer Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Kidney Cancer Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Kidney Cancer Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Kidney Cancer Diagnostics Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Kidney Cancer Diagnostics Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Kidney Cancer Diagnostics Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Kidney Cancer Diagnostics Revenue Market Share by Region (2017-2028)
Figure 58. China Kidney Cancer Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Kidney Cancer Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Kidney Cancer Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Kidney Cancer Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Kidney Cancer Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Kidney Cancer Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Kidney Cancer Diagnostics Sales Market Share by Type (2017-2028)
Figure 65. South America Kidney Cancer Diagnostics Sales Market Share by Application (2017-2028)
Figure 66. South America Kidney Cancer Diagnostics Sales Market Share by Country (2017-2028)
Figure 67. South America Kidney Cancer Diagnostics Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Kidney Cancer Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Kidney Cancer Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Kidney Cancer Diagnostics Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Kidney Cancer Diagnostics Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Kidney Cancer Diagnostics Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Kidney Cancer Diagnostics Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Kidney Cancer Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Kidney Cancer Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Kidney Cancer Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Kidney Cancer Diagnostics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Kidney Cancer Diagnostics in 2021
Figure 79. Manufacturing Process Analysis of Kidney Cancer Diagnostics
Figure 80. Kidney Cancer Diagnostics Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の腎臓がん診断市場2022年：免疫組織化学、尿分析、血液化学検査、その他(Global Kidney Cancer Diagnostics Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の腎臓がん診断市場2022年：免疫組織化学、尿分析、血液化学検査、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp